オスカーヘルスの適時開示・重要契約・決算・その他

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

現行レポート

セクション13または15に基づいて(d)

1934年の証券取引所法の

報告日（報告された最も早い事象の日付）：2026年2月6日

Oscar Health, Inc.

(チャーターで指定された登録者の正確な名前)

デラウェア

001-40154

46-1315570

(法人設立の州またはその他の管轄区域)

(Commission File Number)

(IRS Employer Identification No.)

75 ヴァリック・ストリート、5階

ニューヨーク市、ニューヨーク州、10013

(最高経営責任者の住所）（郵便番号)

(646) 403-3677

(登録者の電話番号（市外局番を含む)

Not applicable

(前回の報告書以降に変更があった場合、旧姓または旧住所)

以下のいずれかの規定に基づく登録者の提出義務を同時に満たすことを意図している場合、該当するチェックボックスにチェックを入れてください：


☐			証券法上の規則425（17 cfr 230.425）に基づく書面でのコミュニケーション。


☐			取引所法の規則14a-12（17 cfr 240.14a-12）に従い、資料を募集しています。


☐			取引所法の規則14d-2(b)(17 cfr 240.14d-2(b))に基づく開始前のコミュニケーション。


☐			取引所法の規則13e-4(c) (17 cfr 240.13e-4(c))に基づく開始前のコミュニケーション。

法第12条(b)項に基づき登録された有価証券：

Title of each class

Trading Symbols

登録されている各取引所の名称

クラスa普通株式、1株あたりの額面が0.00001ドル

OSCR

New York Stock Exchange

登録者が1933年証券法第405条（本章§230.405）または1934年証券取引法第12b-2条（本章§240.12b-2）に定義される新興成長企業である場合は、チェックマークで明示すること。

Emerging growth company ☐

新興成長企業の場合、登録者が証券取引法第13条(a)に基づき提供される新規または改訂された財務会計基準への準拠について延長移行期間を利用しないことを選択した場合は、チェックマークを記入すること。 ☐

Item 1.01. 重要な確定契約の締結

2026年2月6日、オスカー・ヘルス・インク（以下「当社」）は、当社及び特定の金融機関との間で締結された信用契約（以下「信用契約」）に基づき、4億7,500万米ドルの担保付3年物リボルビング・クレジット・ファシリティ（以下（以下「当社」）は、当社、当社の子会社（子会社保証人として）、JPMorgan Chase Bank, N.A.（管理代理人として）、および当該貸付契約の貸付人との間で締結された貸付契約（以下「貸付契約」）に基づき、4億7,500万ドルの担保付3年物リボルビング・クレジット・ファシリティ（以下「リボルビング・クレジット・ファシリティ」）を締結した。本資料において使用されるが定義されていない大文字表記の用語は、クレジット契約において付与された意味を有する。当該リボルビング・クレジット・ファシリティは2029年2月6日に満了し、その時点で未払残高は全額支払期日を迎える。また、当該ファシリティには拡張オプションが含まれており、一定の条件を満たした場合、当社は最大1億ドルの追加枠増額を請求できる。

リボルビング・クレジット・ファシリティに基づく融資の収益金は、一般的な企業目的に利用可能です。債務不履行事由が発生していない場合、リボルビング・クレジット・ファシリティに基づく借入金は、当初、当社の選択により、タームSOFRに年率4.50%のマージンを加えた利率、または代替基準金利に年率3.50%のマージンを加えた利率のいずれかで利息が課されます。 2026年6月30日以降は、適用されるマージンは当社の総純レバレッジ比率に基づき調整され、各タームSOFR貸付に対する適用マージンは3.75%から4.50%の範囲、各代替基準金利貸付に対する適用マージンは2.75%から3.50%の範囲となる。

リボルビング・クレジット・ファシリティには、当初利用可能だが未使用の金額に対して0.50％のコミットメント・フィー（四半期ごとに後払い）およびその他の管理手数料が含まれます。2026年6月30日以降は、適用されるコミットメント・フィーは当社の総純レバレッジ比率に基づき調整され、利用可能だが未使用の金額の0.35％から0.50％の範囲で変動する可能性があります。

当該リボルビング・クレジット・ファシリティは、当社の完全子会社ならびに当社の将来の直接・間接子会社（各々、(i) 重要な政府の同意を必要とする保証、または (ii) ジョイントベンチャーに関する保証を含む、一定の許容される例外を除きます）によって保証されます（以下「保証人」といい、当社と合わせて「ローン当事者」といいます）。

本信用契約には、慣例的な先決条件、表明保証、積極的・消極的契約条項、債務不履行事由及び補償条項が含まれる。当社に関する特定の支配権変更は、リボルビング・クレジット・ファシリティにおける債務不履行事由を構成する。債務不履行事由が発生し、かつ継続している間、貸付人は、リボルビング・クレジット・ファシリティに基づく未返済融資額及びその他全ての債務を直ちに支払期日到来と宣言することができる。リボルビング・クレジット・ファシリティに基づく借入金は、当社が選択により、全額または一部を、前払金または違約金なしで前払いすることができる。また、当社は、前払金または違約金なしでリボルビング・クレジット・ファシリティを終了することを選択することもできる。

さらに、リボルビング・クレジット・ファシリティは、2026年3月31日終了四半期から2026年12月31日終了四半期までの各四半期において、下記の通り特定の財務上の契約条項を遵守することを要求しています：

•当社は、各会計四半期における直接保険料収入が30億ドルを下回ることを認めない。

•当社は、各会計四半期末日における連結調整後EBITDA（過去12ヶ月ベースで算出）が一定の閾値を下回ることを認めない場合がある。

•当社は、各会計四半期末日における流動性（貸付当事者の制限のない現金及び現金同等物に加え、リボルビング・クレジット・ファシリティの未使用額を含む）が2億米ドルを下回らないことを要求する場合があり、このうち少なくとも1億米ドルは貸付当事者の制限のない現金及び現金同等物でなければならない。

リボルビング・クレジット・ファシリティは、2027年3月31日終了の会計四半期から満期日またはそれ以前の終了日まで、各会計四半期において下記の通り特定の財務上の契約条項を遵守することを要求します：

•当社は、総純レバレッジ比率を最大3.50:1.00以内に維持しなければならない。

•会社は最低限の固定費償還倍率を3.00:1.00以上維持しなければならない。

本信用契約に関する上記の説明は、当該契約に基づく当事者の権利の概要に過ぎず、その全文は別紙10.1として添付され、本契約書に参照により組み込まれている本信用契約の全文を参照することにより、その全体が修正されるものである。

通常の業務の過程において、信用契約に基づく貸付人の一部及びその関連会社は、当社に対し投資銀行業務、商業銀行業務、現金管理業務その他の金融サービスを提供しており、また将来提供する場合があり、これに対し報酬を受領しており、また将来受領する可能性がある。

Item 2.02. 営業成績および財務状況

2026年2月10日、当社は2025年12月31日終了の第4四半期および通期の財務実績を発表しました。本発表に関連して発行されたプレスリリースは添付資料として本8-K様式による現況報告書に添付書類99.1として提出され、参照により本報告書に組み込まれます。

本8-K様式による現況報告書における項目2.02及び別紙99.1の情報は、1934年証券取引法（以下「取引法」という）第18条の目的上「提出された」ものとみなされない。また、当該条項に基づく責任の対象となることもない。さらに、当該情報及び添付書類は、1933年証券法または証券取引法に基づく提出書類において、当該提出書類において明示的に特定参照される場合を除き、参照により組み込まれるものとみなされない。

項目2.03. 登録者の直接的な金銭債務または貸借対照表外取引に基づく債務の発生

上記項目1.01に記載された情報は、参照により本項目2.03に組み込まれる。

Item 9.01. 財務諸表および添付資料

(d) 展示物。


Exhibit No.						Description
10.1X						2026年2月6日付貸付契約書オスカー・ヘルス・インク（借入人）、当社の子会社（子会社保証人）、JPモルガン・チェース銀行（管理代理人）、及び当該契約の貸付人各社との間で締結される。
99.1						プレスリリース、2026年2月10日付
104						cover page interactive data file (インラインxbrl文書内に埋め込まれている)。

X 本提出書類の特定のスケジュール（または類似の添付書類）は、規則S-K第601条(a)(5)に基づき省略されています。登録者は、省略されたスケジュール（または類似の添付書類）の写しを、証券取引委員会からの要請に応じて提出することに同意します。

SIGNATURES

1934年証券取引法の規定に基づき、登録者は、本報告書が下記署名者により適式に授権された者として、登録者を代表して署名されるよう適式に手配した。


			Oscar Health, Inc.

			By:						/s/ R. Scott Blackley
			Name:						R. Scott Blackley
			Title:						Chief Financial Officer

Date: February 10, 2026

EX-10.1 2 oscar-revolvingcreditagr.htm EX-10.1 oscar-revolvingcreditagr

Exhibit 10.1 CREDIT AGREEMENT dated as of February 6, 2026, among OSCAR HEALTH, INC., as Borrower, JPMORGAN CHASE BANK N.A., as Administrative Agent and an L/C Issuer; THE LENDERS AND OTHER L/C ISSUERS PARTY HERETO; and JPMORGAN CHASE BANK N.A., and WELLS FARGO SECURITIES, LLC, as Joint Lead Arrangers and Joint Bookrunners and WELLS FARGO SECURITIES, LLC as Syndication Agent and BARCLAYS BANK PLC as Documentation Agent

-i- TABLE OF CONTENTS Page ARTICLE I DEFINITIONS ............................................................................................................1 Section 1.01. Defined Terms .......................................................................................1 Section 1.02. Terms Generally ...................................................................................43 Section 1.03. Pro Forma Calculations ........................................................................44 Section 1.04. Classification of Loans and Borrowings ..............................................45 Section 1.05. [Reserved] ............................................................................................45 Section 1.06. Limited Condition Acquisitions ...........................................................45 Section 1.07. Rates .....................................................................................................46 Section 1.08 Divisions. .............................................................................................47 ARTICLE II THE COMMITMENTS AND CREDIT EXTENSIONS ........................................47 Section 2.01. Revolving Loans ..................................................................................47 Section 2.02. Borrowings, Conversions and Continuations of Loans .......................47 Section 2.03. Letters of Credit ...................................................................................49 Section 2.04. [Reserved] ............................................................................................57 Section 2.05. Prepayments .........................................................................................57 Section 2.06. Optional Reductions of the Revolving Commitments .........................58 Section 2.07. Repayment of Loans ............................................................................58 Section 2.08. Interest ..................................................................................................58 Section 2.09. Fees ......................................................................................................59 Section 2.10. Computation of Interest and Fees ........................................................59 Section 2.11. Evidence of Debt ..................................................................................60 Section 2.12. Payments Generally; Administrative Agent’s Clawback ....................60 Section 2.13. Sharing of Payments by Lenders .........................................................62 Section 2.14. Cash Collateral .....................................................................................62 Section 2.15. Defaulting Lenders ...............................................................................63 Section 2.16. Increase to Commitments ....................................................................65 Section 2.17. Taxes ....................................................................................................67 Section 2.18. Changed Circumstances .......................................................................70 Section 2.19. Benchmark Replacement Setting .........................................................71 Section 2.20. Increased Costs; Reserves on SOFR Loans .........................................72 Section 2.21. Compensation for Losses .....................................................................73 Section 2.22. Mitigation of Obligations; Replacement of Lenders ...........................74 Section 2.23. Survival ................................................................................................74 Section 2.24. Extensions of Loans .............................................................................74 Section 2.25. Termination of Revolving Credit Facility ............................................76 Section 2.26. Refinancing Loans ...............................................................................76 ARTICLE III REPRESENTATIONS AND WARRANTIES .......................................................77 Section 3.01. Organization; Powers ...........................................................................77 Section 3.02. Authorization .......................................................................................77 Section 3.03. Enforceability .......................................................................................77 Section 3.04. Governmental Approvals .....................................................................77

-ii- Section 3.05. Financial Statements ............................................................................78 Section 3.06. No Material Adverse Change ...............................................................78 Section 3.07. Title to Properties; Possession Under Leases ......................................78 Section 3.08. Subsidiaries ..........................................................................................78 Section 3.09. Litigation; Compliance With Laws ......................................................78 Section 3.10. Agreements ..........................................................................................79 Section 3.11. Federal Reserve Regulations ................................................................79 Section 3.12. Investment Company Act ....................................................................79 Section 3.13. Use of Proceeds ....................................................................................79 Section 3.14. Tax Returns ..........................................................................................79 Section 3.15. No Material Misstatements ..................................................................79 Section 3.16. Employee Benefit Plans .......................................................................80 Section 3.17. Environmental Matters .........................................................................80 Section 3.18. Insurance ..............................................................................................80 Section 3.19. Security Documents .............................................................................80 Section 3.20. Location of Real Property and Leased Premises .................................81 Section 3.21. Labor Matters .......................................................................................81 Section 3.22. Solvency ...............................................................................................81 Section 3.23. Insurance Licenses ...............................................................................82 Section 3.24. Sanctioned Persons ..............................................................................82 Section 3.25. Foreign Corrupt Practices Act .............................................................82 Section 3.26. USA PATRIOT Act .............................................................................82 Section 3.27. Intellectual Property .............................................................................82 ARTICLE IV CONDITIONS OF LENDING ...............................................................................83 Section 4.01. All Credit Extensions ...........................................................................83 Section 4.02. Condition .............................................................................................83 ARTICLE V AFFIRMATIVE COVENANTS ..............................................................................85 Section 5.01. Existence; Compliance with Laws; Businesses and Properties ...........85 Section 5.02. Insurance ..............................................................................................85 Section 5.03. Obligations and Taxes ..........................................................................86 Section 5.04. Financial Statements, Reports, Etc ......................................................86 Section 5.05. Litigation and Other Notices ................................................................87 Section 5.06. Information Regarding Collateral ........................................................88 Section 5.07. Maintaining Records; Access to Properties and Inspections ...............88 Section 5.08. Use of Proceeds ....................................................................................89 Section 5.09. Employee Benefits ...............................................................................89 Section 5.10. Compliance with Environmental Laws ................................................89 Section 5.11. [Reserved] ............................................................................................89 Section 5.12. Further Assurances ...............................................................................89 Section 5.13. Post-Closing Requirements ..................................................................90 ARTICLE VI NEGATIVE COVENANTS ...................................................................................90 Section 6.01. Indebtedness .........................................................................................90 Section 6.02. Liens .....................................................................................................92 Section 6.03. Sale and Lease-Back Transactions .......................................................94

-iii- Section 6.04. Investments ..........................................................................................95 Section 6.05. Mergers, Consolidations, Sales of Assets and Acquisitions ................97 Section 6.06. Restricted Payments; Restrictive Agreements .....................................98 Section 6.07. Transactions With Affiliates ................................................................99 Section 6.08. Business of the Borrower and Subsidiaries .......................................100 Section 6.09. Other Indebtedness and Agreements .................................................100 Section 6.10. Financial Covenants ...........................................................................101 Section 6.11. Fiscal Year .........................................................................................101 ARTICLE VII EVENTS OF DEFAULT ....................................................................................101 ARTICLE VIII THE ADMINISTRATIVE AGENT; ETC. ........................................................105 Section 8.01. Appointment and Authorization ........................................................105 Section 8.02. Delegation of Duties ..........................................................................105 Section 8.03. Default; Collateral ..............................................................................105 Section 8.04. Liability of Administrative Agent ......................................................107 Section 8.05. Reliance by Administrative Agent .....................................................108 Section 8.06. Notice of Default ................................................................................110 Section 8.07. Credit Decision; Disclosure of Information by Administrative Agent 110 Section 8.08. Administrative Agent in Its Individual Capacity ...............................111 Section 8.09. Successor Agent .................................................................................111 Section 8.10. Proof of Claim ....................................................................................112 Section 8.11. [Reserved] ..........................................................................................113 Section 8.12. Discretionary Acts and Solicitation of Lender Consent ....................113 Section 8.13. Secured Cash Management Agreements and Secured Hedge Agreements ..........................................................................................................113 Section 8.14. Erroneous Payments ...........................................................................113 ARTICLE IX MISCELLANEOUS .............................................................................................115 Section 9.01. Notices; Electronic Communications ................................................115 Section 9.02. Survival of Agreement .......................................................................117 Section 9.03. Binding Effect ....................................................................................118 Section 9.04. Payments Set Aside ............................................................................118 Section 9.05. Successors and Assigns ......................................................................118 Section 9.06. Expenses; Indemnity ..........................................................................122 Section 9.07. Right of Setoff ....................................................................................124 Section 9.08. Applicable Law ..................................................................................124 Section 9.09. Waivers; Amendment ........................................................................124 Section 9.10. Interest Rate Limitation .....................................................................126 Section 9.11. Entire Agreement ...............................................................................127 Section 9.12. WAIVER OF JURY TRIAL ..............................................................127 Section 9.13. Severability ........................................................................................127 Section 9.14. Counterparts; Integration; Effectiveness; Electronic Execution ........127 Section 9.15. Headings ............................................................................................128 Section 9.16. Jurisdiction; Consent to Service of Process .......................................129 Section 9.17. Confidentiality ...................................................................................129

-iv- Section 9.18. Lender Action ....................................................................................130 Section 9.19. USA PATRIOT Act and Beneficial Ownership Regulation Notice 130 Section 9.20. Certain ERISA Matters ......................................................................130 Section 9.21. Acknowledgement and Consent to Bail-In of Affected Financial Institutions ............................................................................................131 Section 9.22. Replacement of Lenders. ...................................................................132 Section 9.23. No Advisory or Fiduciary Responsibility ..........................................133 Section 9.24. Acknowledgement Regarding Any Supported QFCs. .......................134

-v- SCHEDULES Schedule 1.01(b) - Guarantors Schedule 1.01(d) - Permitted Investors Schedule 2.01 - Lenders and Commitments Schedule 3.08 - Subsidiaries Schedule 3.09 - Litigation Schedule 3.17 - Environmental Matters Schedule 3.18 - Insurance Schedule 3.19(a) - UCC Filing Offices Schedule 3.20(a) - Owned Real Property Schedule 3.20(b) - Leased Real Property Schedule 3.23 - Insurance Licenses Schedule 5.13 - Post-Closing Requirements EXHIBITS Exhibit A - Form of Administrative Questionnaire Exhibit B - Form of Assignment and Acceptance Exhibit C - Form of Borrowing Request Exhibit D - Form of Guarantee and Collateral Agreement Exhibit E - Form of Compliance Certificate Exhibit F - Form of Affiliate Subordination Agreement Exhibit G - Form of Tax Compliance Certificates Exhibit H - Form of Notice of Conversion/Continuation Exhibit I - Form of Note

CREDIT AGREEMENT dated as of February 6, 2026 (this “Agreement”) among OSCAR HEALTH, INC., a Delaware corporation (the “Borrower”), the Lenders (such term and each other capitalized term used but not defined in this introductory statement having the meaning given it in Article I), the L/C Issuers and JPMorgan Chase Bank N.A., as administrative agent (in such capacity, including any successor thereto, the “Administrative Agent”) for the Lenders. The Borrower has requested that Lenders and L/C Issuers commit to extend credit in the form of Revolving Loans and Letters of Credit during the Availability Period, in an aggregate principal amount not in excess of $475,000,000. The proceeds of the Revolving Loans are to be used for working capital and general corporate purposes of the Borrower and the Subsidiaries, including the financing of transactions that are not prohibited by the terms of the Agreement. The Lenders are willing to extend such credit to the Borrower on the terms and subject to the conditions set forth herein. Accordingly, the parties hereto agree as follows: ARTICLE I Definitions Defined Terms. As used in this Agreement, the following terms shall have the meanings specified below: “2025 Capped Call” shall mean any customary capped call option (or substantively equivalent derivative transaction) relating to the common stock of Borrower (or other securities or property following a merger event or other change of the common stock of Borrower) purchased by Borrower in connection with the issuance of the 2025 Convertible Notes, as may be amended in accordance with its terms (provided that any such amendment shall not cause the transaction to no longer be compliant with this definition) and settled in common shares of Borrower (or such other securities or property), cash or a combination thereof; provided that the purchase price for such 2025 Capped Call does not exceed the net proceeds received by the Borrower from the issuance of the 2025 Convertible Notes in connection with such 2025 Capped Call (including, without limitation, the exercise of any over-allotment or initial purchaser’s or underwriter’s option). “2025 Convertible Notes” shall mean the convertible senior or senior subordinated unsecured notes of the Borrower due 2030 issued pursuant to the 2025 Convertible Notes Indenture (as the same may be amended, amended and restated, supplemented or otherwise modified from time to time). “2025 Convertible Notes Documents” shall mean the 2025 Convertible Notes, the 2025 Convertible Notes Indenture and all other documents evidencing, guaranteeing or otherwise governing the terms of the 2025 Convertible Notes. “2025 Convertible Notes Indenture” shall mean that certain Indenture, by and among the Borrower, as issuer, and the trustee named therein, pursuant to which the 2025 Convertible Notes were (as the same may be amended, amended and restated, supplemented or otherwise modified from time to time). “2025 Convertible Notes Issuance Date” shall mean September 18, 2025. “ABR”, when used in reference to any Loan or Borrowing, refers to whether such Loan, or the Loans comprising such Borrowing, are bearing interest at a rate determined by reference to the Alternate Base Rate.

2 “ABR Term SOFR Determination Day” has the meaning specified in the definition of “Term SOFR”. “Accounting Change” means any change in GAAP, any change in the application of GAAP or the adoption of another internationally recognized accounting standard. “Acquired Entity” shall have the meaning assigned to such term in Section 6.04(g). “Additional Lender” means, at any time, any bank, other financial institution or institutional investor that, in any case, is not an existing Lender and that agrees to provide any portion of any, (1) Incremental Commitments in accordance with Section 2.16; or (2) Credit Agreement Refinancing Indebtedness pursuant to a Refinancing Amendment in accordance with Section 2.26; provided that each Additional Lender (other than any Person that is an Affiliate of a Lender or a Related Fund of a Lender at such time) shall be reasonably acceptable to (i) the Borrower, (ii) the Administrative Agent and (iii) the lenders with Fronting Exposure (except that, in the case of clauses (ii) and (iii), only to the extent such Person otherwise would have a consent right to an assignment of such commitments to such lender, such consent not to be unreasonably withheld, conditioned or delayed), in each case to the extent any such consent would be required from the Administrative Agent and/or L/C Issuers under Section 9.05 for an assignment of Loans to such Additional Lender; provided, further, that notwithstanding the foregoing, for purposes of Section 9.05, “Additional Lender” shall not include any Disqualified Institution, unless, the Borrower has consented to such assignment to such entity, in which case such entity will not be considered a Disqualified Institution for the purpose of such assignment. “Administrative Agent” shall have the meaning assigned to such term in the introductory statement to this Agreement. “Administrative Agent Fee” shall mean the fees specified in the Administrative Agent Fee Letter. “Administrative Agent Fee Letter” shall mean that certain administrative agent fee letter dated February 5, 2026 between the Borrower and the Administrative Agent. “Administrative Agent’s Office” shall mean the Administrative Agent’s address and, as appropriate, account as set forth in Section 9.01(b) or such other address or account as the Administrative Agent may from time to time notify the Borrower and the Lenders. “Administrative Questionnaire” shall mean an Administrative Questionnaire in the form of Exhibit A, or such other form as may be supplied from time to time by the Administrative Agent. “Affected Financial Institution” shall mean (a) any EEA Financial Institution or (b) any UK Financial Institution. “Affiliate” shall mean, when used with respect to a specified Person, another Person that directly, or indirectly through one or more intermediaries, Controls or is Controlled by or is under common Control with the Person specified. “Affiliate Subordination Agreement” shall mean an Affiliate Subordination Agreement in the form of Exhibit F pursuant to which intercompany obligations and advances owed by any Loan Party to a non-Loan Party are subordinated to the Obligations.

3 “Agreement” shall have the meaning assigned to such term in the introductory statement hereto. “Agreement Value” shall mean, for each Hedging Agreement, on any date of determination, the maximum aggregate amount (giving effect to any netting agreements) that the Borrower or any of its Subsidiaries would be required to pay if such Hedging Agreement were terminated on such date. “Alternate Base Rate” shall mean, for any day, a rate per annum equal to the highest of (a) the Prime Rate in effect on such day, (b) the Federal Funds Rate in effect on such day plus 0.50% and (c) Term SOFR for a one-month tenor in effect on such day plus 1.00 %; provided that if Alternate Base Rate as so determined shall ever be less than the Floor, then Alternate Base Rate shall be deemed to be the Floor. Any change in the ABR shall take effect simultaneously with the corresponding change or changes in the Prime Rate, the Federal Funds Rate or Term SOFR, as applicable (provided that clause (c) shall not be applicable during any period in which Term SOFR is unavailable or unascertainable). “Applicable Insurance Code” shall mean, as to any Regulated Insurance Company, the insurance code or other statute of any state where such Regulated Insurance Company or other Person is domiciled or doing insurance business and any successor statute of similar import, together with the regulations thereunder, as amended or otherwise modified and in effect from time to time. “Applicable Insurance Regulatory Authority” shall mean, when used with respect to any Regulated Insurance Company, the insurance department or similar administrative authority or agency located in (a) each state or other jurisdiction in which such Regulated Insurance Company is domiciled or (b) to the extent asserting regulatory jurisdiction over such Regulated Insurance Company, the insurance department, authority or agency in each state or other jurisdiction in which such Regulated Insurance Company is licensed, and shall include any federal or national insurance regulatory department, authority or agency that may be created that asserts regulatory jurisdiction over such Regulated Insurance Company. “Applicable Law” shall mean all applicable provisions of constitutions, laws, statutes, ordinances, rules, treaties, regulations, permits, licenses, approvals, interpretations and orders of Governmental Authorities and all orders and decrees of all courts and arbitrators. “Applicable Commitment Fee” shall mean a percentage per annum equal to, 0.50%; provided that from and after the third Business Day after the date on which the Administrative Agent shall have received the applicable financial statements and a Compliance Certificate pursuant to Section 5.04(d) calculating the Total Net Leverage Ratio in respect of the first full fiscal quarter ending after the Closing Date, the Applicable Commitment Fee shall be the applicable rate per annum set forth below under the caption “Commitment Fee”, respectively, based upon the Total Net Leverage Ratio as of the last day of the most recent Test Period as set forth in the most recent Compliance Certificate received by the Administrative Agent pursuant to Section 5.04(d):

4 Total Net Leverage Ratio Commitment Fee Above 3.50 to 1.00 0.50% Equal to or below 3.50:1.00 but above 3.00:1.00 0.45% Equal to or below 3.00:1.00 but above 2.50:1.00 0.40% Equal to or below 2.50 to 1.00 0.35% No change in the Applicable Commitment Fee shall be effective until three Business Days after the date on which the Administrative Agent shall have received the applicable financial statements and a Compliance Certificate calculating the Total Net Leverage Ratio. The Total Net Leverage Ratio shall be calculated on a pro forma basis as set forth in the applicable Compliance Certificate. At any time the Borrower has not submitted to the Administrative Agent the applicable information as and when required under Section 5.04(d), the Applicable Commitment Fee shall be determined as if the Total Net Leverage Ratio were in excess of 3.50 to 1.00; provided that such pricing shall apply at the option of the Administrative Agent or at the request of the Required Lenders as of the first Business Day after the date on which such Compliance Certificate was required to have been delivered but has not been delivered pursuant to Section 5.04(d) and shall continue to so apply to and including the date on which such Compliance Certificate is so delivered. In the event that any financial statement or certificate delivered pursuant to Section 5.04(d) is determined to be inaccurate, and such inaccuracy, if corrected, would have led to the application of a higher Applicable Commitment Fee for any period (an “Applicable Commitment Fee Period”) than the Applicable Commitment Fee applied for such Applicable Commitment Fee Period, then (a) the Borrower shall promptly (and in any event within five Business Days) following such determination deliver to the Administrative Agent correct financial statements and certificate required by Section 5.04(d) for such Applicable Commitment Fee Period, (b) the Applicable Commitment Fee for such Applicable Commitment Fee Period shall be determined as if the Total Net Leverage Ratio were determined based on the amounts set forth in such correct financial statements and certificates and (c) the Borrower shall promptly (and in any event within ten Business Days) following delivery of such corrected financial statements and certificate pay to the Administrative Agent the accrued additional amounts owing as a result of such increased Applicable Commitment Fee for such Applicable Commitment Fee Period. Notwithstanding anything to the contrary set forth herein, the provisions of this final paragraph (but not any of the other provisions of this definition preceding this final paragraph) may be amended or waived as provided in Section 9.09(b)(i). “Applicable Margin” shall mean a percentage per annum equal to, (i) for Benchmark Rate Loans, 4.50% and (ii) for ABR Loans, 3.50%; provided that from and after the third Business Day after the date on which the Administrative Agent shall have received the applicable financial statements and a Compliance Certificate pursuant to Section 5.04(d) calculating the Total Net Leverage Ratio in respect of the first full

5 fiscal quarter ending after the Closing Date, the Applicable Margin shall be the applicable rate per annum set forth below under the caption “Applicable Margin (Term SOFR)” or “Applicable Margin (ABR)”, respectively, based upon the Total Net Leverage Ratio as of the last day of the most recent Test Period as set forth in the most recent Compliance Certificate received by the Administrative Agent pursuant to Section 5.04(d): Total Net Leverage Ratio Applicable Margin (Term SOFR) Applicable Margin (ABR) Above 3.50 to 1.00 4.50% 3.50% Equal to or below 3.50:1.00 but above 3.00:1.00 4.25% 3.25% Equal to or below 3.00:1.00 but above 2.50:1.00 4.00% 3.00% Equal to or below 2.50 to 1.00 3.75% 2.75% No change in the Applicable Margin shall be effective until three Business Days after the date on which the Administrative Agent shall have received the applicable financial statements and a Compliance Certificate calculating the Total Net Leverage Ratio. The Total Net Leverage Ratio shall be calculated on a pro forma basis as set forth in the applicable Compliance Certificate. At any time the Borrower has not submitted to the Administrative Agent the applicable information as and when required under Section 5.04(d), the Applicable Margin shall be determined as if the Total Net Leverage Ratio were in excess of 3.50 to 1.00; provided that such pricing shall apply at the option of the Administrative Agent or at the request of the Required Lenders as of the first Business Day after the date on which such Compliance Certificate was required to have been delivered but has not been delivered pursuant to Section 5.04(d) and shall continue to so apply to and including the date on which such Compliance Certificate is so delivered. In the event that any financial statement or certificate delivered pursuant to Section 5.04(d) is determined to be inaccurate, and such inaccuracy, if corrected, would have led to the application of a higher Applicable Margin for any period (an “Applicable Margin Period”) than the Applicable Margin applied for such Applicable Margin Period, then (a) the Borrower shall promptly (and in any event within five Business Days) following such determination deliver to the Administrative Agent correct financial statements and certificate required by Section 5.04(d) for such Applicable Margin Period, (b) the Applicable Margin for such Applicable Margin Period shall be determined as if the Total Net Leverage Ratio were determined based on the amounts set forth in such correct financial statements and certificates and (c) the Borrower shall promptly (and in any event within ten Business Days) following delivery of such corrected financial statements and certificate pay to the Administrative Agent the accrued additional amounts owing as a result of such increased Applicable Margin for such Applicable Margin Period. Notwithstanding anything to the contrary set forth herein, the provisions of this final paragraph (but not any of the other provisions of this definition preceding this final paragraph) may be amended or waived as provided in Section 9.09(b)(i). “Applicable Percentage” shall mean, with respect to any Lender at any time, the percentage (carried out to the ninth decimal place) of the aggregate Revolving Commitments represented by such Lender’s Revolving Commitment at such time; provided, that, if the commitment of each Lender to make Revolving Loans and

6 the obligation of each L/C Issuer to make L/C Credit Extensions have been terminated pursuant to Article VII or if the aggregate Revolving Commitments have expired, then the Applicable Percentage with respect to each Lender’s Revolving Commitment shall be determined based on the Applicable Percentage of such Lender’s Revolving Commitment most recently in effect, giving effect to any subsequent assignments. The initial Applicable Percentages of each Lender are set forth opposite the name of such Lender on Schedule 2.01 or in the Assignment and Acceptance pursuant to which such Lender becomes a party hereto or in any documentation executed by such Lender pursuant to this Agreement. The Applicable Percentages shall be subject to adjustment as provided in Section 2.15. “Approved Borrower Portal” shall have the meaning assigned to such term in Section 9.01. “Arranger” shall mean each of JPMorgan Chase Bank N.A. and Wells Fargo Securities, LLC, in each case in their respective capacities as a joint lead arranger and a joint bookrunner, Wells Fargo Securities, LLC as syndication agent and Barclays Bank plc as documentation agent. . “Asset Sale” shall mean the sale, division, transfer or other disposition (by way of merger, casualty, condemnation or otherwise) by the Borrower or any of its Subsidiaries to any Person other than the Borrower or any Guarantor of (a) any Equity Interests of any of the Subsidiaries (other than directors’ qualifying shares) or (b) any other assets of the Borrower or any of the Subsidiaries (other than (i) inventory, damaged, obsolete or worn out assets, assets no longer used or useful in the business of the Borrower and its Subsidiaries, scrap, cash and Permitted Investments, in each case disposed of in the ordinary course of business, (ii) dispositions between or among Excluded Subsidiaries, (iii) trade-ins and exchanges of assets with third parties conducted in the ordinary course of business to the extent substantially comparable (or better) assets useful in the operation of the business of the Borrower and its Subsidiaries are obtained in exchange therefor, (iv) the discount, write-off or disposition, in each case, on a non-recourse basis and in the ordinary course of business consistent with past practice, of accounts receivable in connection with the collection or compromise thereof (and not as part of an accounts receivable financing transaction), (v) the termination of leases, surrender or sublease of real or personal property in the ordinary course of business that do not interfere in any material respect with the business of the Borrower or its Subsidiaries, (vi) dispositions in connection with Casualty Events, (vii) the incurrence of Liens expressly permitted pursuant to Section 6.02, (viii) Investments expressly permitted pursuant to Section 6.04, (ix) the unwinding of any Hedging Agreement expressly permitted hereunder pursuant to its terms, (x) leases, subleases, licenses or sublicenses of real or personal property in the ordinary course of business not interfering in any material respect with the business of the Borrower or any of its Subsidiaries, (xi) the issuance, sale, transfer or other disposition of Equity Interests (or any contractual rights equivalent thereto) in, or any assets of, any Subsidiary in connection with a Joint Venture; provided that, after giving effect thereto and any Investments made pursuant to Section 6.04(h), no more than the greater of (a) $50,000,000 and (b) 25% (or, if (x) such Investments are made in the form of cash or Permitted Investments and (y) Liquidity is less than $200,000,000 (calculated after to giving effect to the proposed disposition), 15%) of Consolidated Total Assets are owned (whether directly or through a percentage interest profit sharing or similar arrangement) by any Person that is not the Borrower or a Subsidiary; provided, further that no disposition may be made under this clause (xi) with respect to any Joint Venture that is not a Subsidiary of the Borrower (such transaction contemplated by this clause (xi), a “Joint Venture Disposition”), (xii) any Joint Venture Disposition consummated prior to the Closing Date, and (xiii) any sale, transfer or other disposition or series of related sales, transfers or other dispositions having a value not in excess of the greater of $5,000,000 and (y) an amount equal to the Equivalent Percentage of the amount in the preceding clause (x) multiplied by Consolidated Total Assets per annum). “Assignment and Acceptance” shall mean an assignment and acceptance entered into by a Lender and an Eligible Assignee, and accepted by the Administrative Agent, in the form of Exhibit B or such other form as shall be approved by the Administrative Agent.

7 “Auto-Extension Letter of Credit” has the meaning specified in Section 2.03(b)(iii). “Availability Period” shall mean the period from and including the Closing Date to the earliest of (a) the Maturity Date with respect to the Revolving Loans, (b) the date of termination of the Revolving Commitments pursuant to Section 2.06 and (c) the date of termination of the commitment of each Lender to make Revolving Loans and of the obligations of each L/C Issuer to make L/C Credit Extensions pursuant to Article VII. “Available Tenor” shall mean, as of any date of determination and with respect to the then-current Benchmark, as applicable, (a) if such Benchmark is a term rate, any tenor for such Benchmark (or component thereof) that is or may be used for determining the length of an interest period pursuant to this Agreement or (b) otherwise, any payment period for interest calculated with reference to such Benchmark (or component thereof) that is or may be used for determining any frequency of making payments of interest calculated with reference to such Benchmark, in each case, as of such date and not including, for the avoidance of doubt, any tenor for such Benchmark that is then-removed from the definition of “Interest Period” pursuant to Section 2.19(d). “Bail-In Action” shall mean the exercise of any Write-Down and Conversion Powers by the applicable Resolution Authority in respect of any liability of an Affected Financial Institution. “Bail-In Legislation” shall mean, (a) with respect to any EEA Member Country implementing Article 55 of Directive 2014/59/EU of the European Parliament and of the Council of the European Union, the implementing law, regulation, rule or requirement for such EEA Member Country from time to time which is described in the EU Bail-In Legislation Schedule and (b) with respect to the United Kingdom, Part I of the United Kingdom Banking Act 2009 (as amended from time to time) and any other law, regulation or rule applicable to the United Kingdom relating to the resolution of unsound or failing banks, investment firms or other financial institutions or their affiliates (other than through liquidation, administration or other insolvency proceedings). “Benchmark” shall mean, initially, the Term SOFR Reference Rate; provided that if a Benchmark Transition Event has occurred with respect to the Term SOFR Reference Rate or the then-current Benchmark, then “Benchmark” shall mean the applicable Benchmark Replacement to the extent that such Benchmark Replacement has replaced such prior benchmark rate pursuant to Section 2.19(a). “Benchmark Replacement” shall mean, with respect to any Benchmark Transition Event, the sum of: (a) the alternate benchmark rate that has been selected by the Administrative Agent and the Borrower giving due consideration to (i) any selection or recommendation of a replacement benchmark rate or the mechanism for determining such a rate by the Relevant Governmental Body or (ii) any evolving or then- prevailing market convention for determining a benchmark rate as a replacement to the then-current Benchmark for Dollar-denominated syndicated credit facilities at such time and (b) the related Benchmark Replacement Adjustment; provided that, if such Benchmark Replacement as so determined would be less than the Floor, such Benchmark Replacement will be deemed to be the Floor for the purposes of this Agreement and the other Loan Documents. “Benchmark Replacement Adjustment” shall mean, with respect to any replacement of the then-current Benchmark with an Unadjusted Benchmark Replacement for any applicable Available Tenor, the spread adjustment, or method for calculating or determining such spread adjustment, (which may be a positive or negative value or zero) that has been selected by the Administrative Agent and the Borrower giving due consideration to (a) any selection or recommendation of a spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of such Benchmark with the applicable Unadjusted Benchmark Replacement by the Relevant Governmental Body or (b) any evolving or then-

8 prevailing market convention for determining a spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of such Benchmark with the applicable Unadjusted Benchmark Replacement for Dollar-denominated syndicated credit facilities at such time. “Benchmark Replacement Date” shall mean the earliest to occur of the following events with respect to the then-current Benchmark: (a) in the case of clause (a) or (b) of the definition of “Benchmark Transition Event,” the later of (i) the date of the public statement or publication of information referenced therein and (ii) the date on which the administrator of such Benchmark (or the published component used in the calculation thereof) permanently or indefinitely ceases to provide such Benchmark (or such component thereof) or, if such Benchmark is a term rate, all Available Tenors of such Benchmark (or such component thereof); or (b) in the case of clause (c) of the definition of “Benchmark Transition Event,” the first date on which such Benchmark (or the published component used in the calculation thereof) has been or, if such Benchmark is a term rate, all Available Tenors of such Benchmark (or such component thereof) have been determined and announced by the regulatory supervisor for the administrator of such Benchmark (or such component thereof) to be non-representative; provided that such non-representativeness will be determined by reference to the most recent statement or publication referenced in such clause (c) and even if such Benchmark (or such component thereof) or, if such Benchmark is a term rate, any Available Tenor of such Benchmark (or such component thereof) continues to be provided on such date. For the avoidance of doubt, if such Benchmark is a term rate, the “Benchmark Replacement Date” will be deemed to have occurred in the case of clause (a) or (b) with respect to any Benchmark upon the occurrence of the applicable event or events set forth therein with respect to all then-current Available Tenors of such Benchmark (or the published component used in the calculation thereof). “Benchmark Transition Event” shall mean the occurrence of one or more of the following events with respect to the then-current Benchmark: (a) a public statement or publication of information by or on behalf of the administrator of such Benchmark (or the published component used in the calculation thereof) announcing that such administrator has ceased or will cease to provide such Benchmark (or such component thereof) or, if such Benchmark is a term rate, all Available Tenors of such Benchmark (or such component thereof), permanently or indefinitely; provided that, at the time of such statement or publication, there is no successor administrator that will continue to provide such Benchmark (or such component thereof) or, if such Benchmark is a term rate, any Available Tenor of such Benchmark (or such component thereof); (b) a public statement or publication of information by the regulatory supervisor for the administrator of such Benchmark (or the published component used in the calculation thereof), the Federal Reserve Board, the Federal Reserve Bank of New York, an insolvency official with jurisdiction over the administrator for such Benchmark (or such component), a resolution authority with jurisdiction over the administrator for such Benchmark (or such component) or a court or an entity with similar insolvency or resolution authority over the administrator for such Benchmark (or such component), which states that the administrator of such Benchmark (or such component) has ceased or will cease to provide such Benchmark (or such component thereof) or, if such Benchmark is a term rate, all Available Tenors of such Benchmark (or such component thereof) permanently or indefinitely; provided that, at the time of such statement or publication, there is no successor administrator that will continue to provide such Benchmark (or such component thereof) or, if such Benchmark is a term rate, any Available Tenor of such Benchmark (or such component thereof); or

9 (c) a public statement or publication of information by the regulatory supervisor for the administrator of such Benchmark (or the published component used in the calculation thereof) announcing that such Benchmark (or such component thereof) or, if such Benchmark is a term rate, all Available Tenors of such Benchmark (or such component thereof) are not, or as of a specified future date will not be, representative. For the avoidance of doubt, if such Benchmark is a term rate, a “Benchmark Transition Event” will be deemed to have occurred with respect to any Benchmark if a public statement or publication of information set forth above has occurred with respect to each then-current Available Tenor of such Benchmark (or the published component used in the calculation thereof). “Benchmark Transition Start Date” shall mean, in the case of a Benchmark Transition Event, the earlier of (a) the applicable Benchmark Replacement Date and (b) if such Benchmark Transition Event is a public statement or publication of information of a prospective event, the 90th day prior to the expected date of such event as of such public statement or publication of information (or if the expected date of such prospective event is fewer than 90 days after such statement or publication, the date of such statement or publication). “Benchmark Unavailability Period” shall mean, the period (if any) (a) beginning at the time that a Benchmark Replacement Date has occurred if, at such time, no Benchmark Replacement has replaced the then-current Benchmark for all purposes hereunder and under any Loan Document in accordance with Section 2.19 and (b) ending at the time that a Benchmark Replacement has replaced the then-current Benchmark for all purposes hereunder and under any Loan Document in accordance with Section 2.19. “Beneficial Ownership Certification” shall mean a certification regarding beneficial ownership required by the Beneficial Ownership Regulation. “Beneficial Ownership Regulation” shall mean 31 C.F.R. § 1010.230. “Benefit Plan” shall mean any of (a) an “employee benefit plan” (as defined in ERISA) that is subject to Title I of ERISA, (b) a “plan” as defined in and subject to Section 4975 of the Code or (c) any Person whose assets include (for purposes of ERISA Section 3(42) or otherwise for purposes of Title I of ERISA or Section 4975 of the Code) the assets of any such “employee benefit plan” or “plan”. “Board” shall mean the Board of Governors of the Federal Reserve System of the United States of America and any successor thereto. “Borrower” shall have the meaning assigned to such term in the introductory statement to this Agreement. “Borrower Materials” shall have the meaning assigned to such term in Section 9.01. “Borrower Communications” shall mean, collectively, any Borrowing Request, notice of prepayment, notice requesting the issuance, amendment or extension of a Letter of Credit or other notice, demand, communication, information, document or other material provided by or on behalf of the Borrower pursuant to any Loan Document or the transactions contemplated therein which is distributed by the Borrower to the Administrative Agent through an Approved Borrower Portal. “Borrowing” shall mean a borrowing consisting of Loans of the same Type made, converted or continued on the same date and, in the case of a SOFR Borrowing, having the same Interest Period.

10 “Borrowing Request” shall mean a written request by the Borrower in accordance with the terms of Section 2.02 and substantially in the form of Exhibit C, or such other form as shall be approved by the Administrative Agent. “Business Day” shall mean any day that is not a Saturday, Sunday or other day on which the Federal Reserve Bank of New York or other banking institutions in such state are authorized or required by Law to close and in relation to Loans referencing the Term SOFR Rate and any interest rate settings, fundings, disbursements, settlements or payments of any such Loans referencing the Term SOFR Rate or any other dealings of such Loans referencing the Term SOFR Rate, any such day that is a U.S. Government Securities Business Day. “Capital Lease Obligations” of any Person shall mean the obligations of such Person to pay rent or other amounts under any lease of (or other arrangement conveying the right to use) real or personal property, or a combination thereof, which obligations are required to be classified and accounted for as finance or capital leases on a balance sheet of such Person under GAAP and the amount of such obligations shall be the capitalized amount thereof determined in accordance with GAAP as of such date; provided, that in no event shall obligations under an operating lease or a lease that would have been an operating lease prior to the adoption of ASC 842 be included in Capital Lease Obligations. “Cash Collateralize” shall mean to pledge and deposit with or deliver to the Administrative Agent, for the benefit of one or more of the L/C Issuers or the Lenders, as collateral for the L/C Obligations or obligations of the Lenders to fund participations in respect of L/C Obligations, cash or deposit account balances or, if the Administrative Agent and the applicable L/C Issuer shall agree in their sole discretion, other credit support, in each case pursuant to documentation in form and substance satisfactory to the Administrative Agent and such L/C Issuer. “Cash Collateral” shall have a meaning correlative to the foregoing and shall include the proceeds of such cash collateral and other credit support. “Cash Management Agreement” shall mean any agreement to provide treasury or cash management services, including deposit accounts, overnight draft, credit cards, debit cards, p-cards (including purchasing cards and commercial cards), funds transfer, automated clearinghouse, zero balance accounts, returned check concentration, controlled disbursement, lockbox, account reconciliation and reporting and trade finance services, merchant services and other cash management services. “Cash Management Bank” shall mean any Person in its capacity as a party to a Secured Cash Management Agreement with the Borrower or any Guarantor; provided, that, (a) at the time such Person enters into such Cash Management Agreement, such Person is a Lender or an Affiliate of a Lender (even if thereafter such Person ceases to be a Lender or such Person’s Affiliate ceases to be a Lender) or (b) such Cash Management Agreement exists at the time such Person or Affiliate of such Person becomes a Lender (even if thereafter such Person ceases to be a Lender or such Person’s Affiliate ceases to be a Lender). “Casualty Event” shall mean any casualty or other insured damage to, or any taking under power of eminent domain or by condemnation or similar proceeding of, any property or asset of the Borrower or any other Loan Party. “CFC” shall mean any Subsidiary that is a ‘controlled foreign corporation’ within the meaning of Section 957 of the Code. A “Change in Control” shall be deemed to have occurred if (a) any “person” or “group” (within the meaning of Rule 13d-5 of the Securities Exchange Act of 1934 as in effect on the date hereof), other than the Permitted Investors, shall own, directly or indirectly, beneficially or of record, shares representing more than 40% of the aggregate ordinary voting power represented by the issued and outstanding capital stock

11 of the Borrower or (b) any change in control (or similar event, however denominated) with respect to the Borrower or any Subsidiary shall occur under and as defined in any indenture or agreement in respect of Material Indebtedness to which the Borrower or any Subsidiary is a party. “Change in Law” shall mean the occurrence, after the date of this Agreement, of any of the following: (a) the adoption or taking effect of any law, rule, regulation or treaty, (b) any change in any law, rule, regulation or treaty or in the administration, interpretation, implementation or application thereof by any Governmental Authority or (c) the making or issuance of any request, rule, guideline or directive (whether or not having the force of law) by any Governmental Authority; provided, that, notwithstanding anything herein to the contrary, (x) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith or in the implementation thereof and (y) all requests, rules, guidelines or directives promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to Basel III, shall in each case be deemed to be a “Change in Law”, regardless of the date enacted, adopted, issued or implemented. “Charges” shall have the meaning assigned to such term in Section 9.10. “Class” when used in reference to (a) any Loan, refers to whether such Loan, or the Loans comprising such Borrowing, are Loans or Extended Loans or (b) any Commitment, refers to whether such Commitment is a Commitment in respect of Loans or a Commitment in respect of a Class of Loans to be made pursuant to an Extension Amendment. “Closing Date” shall mean the first date the conditions precedent set forth in Section 4.02 have been satisfied or waived in accordance with Section 9.09. “Code” shall mean the Internal Revenue Code of 1986, as amended from time to time. “Collateral” shall mean all the “Collateral” as defined in any Security Document. “Commitment” shall mean a Revolving Commitment. “Commitment Fee” has the meaning specified in Section 2.09(a). “Competitor” shall mean any Person that is a bona fide direct competitor (which may include a customer or supplier which is also a competitor or potential competitor) of the Borrower or any of its Subsidiaries in the same industry or a substantially similar industry. “Compliance Certificate” means a certificate substantially in the form of Exhibit E. “Conforming Changes” shall mean, with respect to either the use or administration of Term SOFR or the use, administration, adoption or implementation of any Benchmark Replacement, any technical, administrative or operational changes (including changes to the definition of “Alternate Base Rate,” the definition of “Business Day,” the definition of “U.S. Government Securities Business Day,” the definition of “Interest Period” or any similar or analogous definition (or the addition of a concept of “interest period”), timing and frequency of determining rates and making payments of interest, timing of borrowing requests or prepayment, conversion or continuation notices, the applicability and length of lookback periods, the applicability of Section 2.21 and other technical, administrative or operational matters) that the Administrative Agent decides may be appropriate to reflect the adoption and implementation of any such rate or to permit the use and administration thereof by the Administrative Agent in a manner substantially

12 consistent with market practice (or, if the Administrative Agent decides that adoption of any portion of such market practice is not administratively feasible or if the Administrative Agent determines that no market practice for the administration of any such rate exists, in such other manner of administration as the Administrative Agent decides is reasonably necessary in connection with the administration of this Agreement and the other Loan Documents). “Connection Income Taxes” shall mean Other Connection Taxes that are imposed on or measured by net income (however denominated) or that are franchise Taxes or branch profits Taxes. “Consolidated Adjusted EBITDA” shall mean: (1) with respect to determining compliance with Section 6.10(c) for any Test Period, the net income (or loss) for the Borrower and its Subsidiaries on a consolidated basis for such Test Period before (i) interest expense, including interest expense associated with debt arrangements, amortization of debt issuance costs and discounts and revolving credit facility fees, (ii) income tax expense (benefit), including changes to the Borrower’s current and deferred federal and state tax assets and liabilities, (iii) depreciation and amortization, (iv) stock-based compensation expense, including expense and changes in fair value associated with liability-classified awards and (v) other non-recurring or non-cash items, in each case of clauses (i) through (v), as publicly reported by the Borrower for the applicable Test Period, and (2) for any other purpose under this Agreement, including with respect to determining compliance with Sections 6.10(d) and (e) for any Test Period, the Consolidated Net Income of the Borrower for such Test Period: (a) increased, without duplication, by the following items (solely to the extent deducted (and not excluded) in calculating Consolidated Net Income, other than in respect of clauses (ii)(B), (xii), (xx) and (xxi) below) of the Borrower and its Subsidiaries for such Test Period determined on a consolidated basis in accordance with GAAP: (ii) interest expense, including (A) imputed interest on Capitalized Lease Obligations and Attributable Indebtedness (which, in each case, will be deemed to accrue at the interest rate reasonably determined by a Responsible Officer of the Borrower to be the rate of interest implicit in such Capitalized Lease Obligations), (B) commissions, discounts and other fees, charges and expenses owed with respect to letters of credit, bankers’ acceptance financing, surety and performance bonds and receivables financings, (C) amortization and write-offs of deferred financing fees, debt issuance costs, debt discounts, commissions, fees, premium and other expenses, as well as expensing of bridge, commitment or financing fees, (D) payments made in respect of hedging obligations or other derivative instruments entered into for the purpose of hedging interest rate risk, (E) cash contributions to any employee stock ownership plan or similar trust to the extent such contributions are used by such plan or trust to pay interest or fees to any Person (other than such Person or a wholly owned Subsidiary) in connection with Indebtedness incurred by such plan or trust, (F) all interest paid or payable with respect to discontinued operations, (G) the interest portion of any deferred payment obligations, (H) all interest on any Indebtedness that is (1) Indebtedness of others secured by any Lien on property owned or acquired by such Person or its Subsidiaries, whether or not the obligations secured thereby have been assumed, but limited to the fair market value of such property or (2) contingent obligations in respect of Indebtedness; provided that such interest expense shall be calculated after giving effect to Hedging Agreements related to interest rates (including associated costs), but excluding unrealized gains and losses with respect to such Hedging

13 Agreements and (I) fees and expenses paid to the Administrative Agent (in its capacity as such and for its own account) pursuant to the Loan Documents; plus (iii) taxes based on gross receipts, income, profits or revenue or capital, franchise, excise, property, commercial activity, sales, use, unitary or similar taxes, and foreign withholding taxes, including (A) penalties and interest and (B) tax distributions made to any direct or indirect holders of Equity Interests of such Person in respect of any such taxes attributable to such Person and/or its Subsidiaries or pursuant to a tax sharing arrangement or as a result of a tax distribution or repatriated funds; plus (iv) depreciation expense and amortization expense (including amortization and similar charges related to goodwill, customer relationships, trade names, databases, technology, software, internal labor costs, deferred financing fees or costs and other intangible assets); plus (v) non-cash items (provided that if any such non-cash item represents an accrual or reserve for potential cash items in any future period, (A) the Borrower may determine not to add back such non-cash item in the current Test Period and (B) to the extent the Borrower decides to add back such non-cash expense or charge, the cash payment in respect thereof in such future period will be subtracted from Consolidated Adjusted EBITDA in such future period), including the following: (1) non-cash expenses in connection with, or resulting from, stock option plans, employee benefit plans or agreements or post-employment benefit plans or agreements, or grants or sales of stock, stock appreciation or similar rights, stock options, restricted stock, preferred stock or other similar rights, (2) non-cash currency translation losses related to changes in currency exchange rates (including re-measurements of Indebtedness (including intercompany Indebtedness) and any net non-cash loss resulting from hedge agreements for currency exchange risk), (3) non-cash losses, expenses, charges or negative adjustments attributable to the movement in the mark-to-market valuation of hedge agreements or other derivative instruments, including the effect of FASB Accounting Standards Codification 815 and International Accounting Standard No. 9 and their respective related pronouncements and interpretations, (4) non-cash charges for deferred tax asset valuation allowances, (5) non- cash impairment charge or asset write-off or write-down related to intangible assets (including goodwill), long-lived assets, and Investments in debt and equity securities, (6) non-cash charges or losses resulting from any purchase accounting adjustment or any step- ups with respect to re-valuing assets and liabilities in connection with the Transactions or any Investments either existing or arising after the Closing Date, (7) non-cash losses from Investments either existing or arising after the Closing Date recorded using the equity method, (8) the excess of GAAP rent expense over actual cash rent paid during such period due to the use of straight line rent for GAAP purposes and (9) any non-cash interest expense; plus (vi) unusual, extraordinary, infrequent, or non-recurring items, whether or not classified as such under GAAP; plus (vii) charges, costs, losses, expenses, reserves or other items related to or incurred in connection with the following: (A) restructuring (including restructuring charges or reserves, whether or not classified as such under GAAP), severance, relocation, consolidation, integration or other similar items, (B) strategic and/or business initiatives; business optimization initiatives (including costs and expenses relating to reporting systems and technology initiatives); strategic initiatives; retention, severance, and similar

14 items; systems establishment costs; systems conversion and integration costs; contract termination costs; recruiting and relocation costs and expenses; costs, expenses and charges incurred in connection with curtailments or modifications to pension and post-retirement employee benefits plans; costs associated with start-up, pre-opening, opening, closure, transition and/or consolidation of operations, offices and facilities, including in connection with the Transactions and any acquisition or other Investment permitted hereunder, any acquisition or other Investment; new systems design and implementation; and consulting fees and expenses relating to enhancing accounting functions, (C) business or facilities (including greenfield facilities) start-up, opening, transition, consolidation, shut-down and closing, (D) signing, retention and completion bonuses, (E) severance, relocation or recruiting, (F) a public company registration, listing, compliance, reporting or related activity, (G) litigation (including threatened litigation), any investigation or proceeding (or any threatened investigation or proceeding) by a regulatory, governmental or law enforcement body (including any attorney general), and (H) casualty events or asset sales outside the ordinary course of business; plus (viii) all (A) costs, fees and expenses relating to the Transactions, (B) costs, fees and expenses (including diligence and integration costs) incurred in connection with (i) Investments in any Person, acquisitions of the Equity Interests of any Person, Permitted Acquisitions and other acquisitions, including acquisitions of all or a material portion of the assets of any Person or constituting a line of business of any Person, and financings related to any of the foregoing or to the capitalization of any Loan Party or any Subsidiary or (ii) other transactions that are out of the ordinary course of business of such Person and its Subsidiaries (in each case of clause (i) and (ii), including transactions considered or proposed but not consummated), including equity issuances, Investments, acquisitions, dispositions, recapitalizations, mergers, option buyouts and the incurrence, modification or repayment of Indebtedness (including all consent fees, premium and other amounts payable in connection therewith) and (C) non-operating professional fees, costs and expenses; plus (ix) items reducing Consolidated Net Income to the extent (A) covered by a binding indemnification or refunding obligation or insurance to the extent actually paid or reasonably expected to be paid within one year after the end of such period, (B) paid or payable (directly or indirectly) by a third party that is not a Loan Party or a Subsidiary (except to the extent such payment gives rise to reimbursement obligations) or with the proceeds of a contribution to equity capital of such Person by a third party that is not a Loan Party or a Subsidiary or (C) such Person is, directly or indirectly, reimbursed for such item by a third party; plus (x) [reserved]; plus (xi) the effects of purchase accounting, fair value accounting or recapitalization accounting (including the effects of adjustments pushed down to such Person and its Subsidiaries) and the amortization, write-down or write-off of any such amount; plus (xii) to the extent included in the determination of Consolidated Net Income for such Test Period, proceeds of business interruption insurance actually received; plus (xiii) minority interest expense consisting of income attributable to Equity Interests held by third parties in any non-wholly owned Subsidiary; plus

15 (xiv) all charges, costs, expenses, accruals or reserves in connection with the rollover, acceleration or payout of Equity Interests held by officers or employees and all losses, charges and expenses related to payments made to holders of options or other derivative Equity Interests of such Person or any direct or indirect parent thereof in connection with, or as a result of, any distribution being made to equity holders of such Person or any direct or indirect parent thereof, including (A) payments made to compensate such holders as though they were equity holders at the time of, and entitled to share in, such distribution, and (B) all dividend equivalent rights owed pursuant to any compensation or equity arrangement; plus (xv) expenses, charges and losses resulting from earn-outs and contingent consideration obligations and payments in respect of purchase price adjustments; in each case, made in connection with a Permitted Acquisition or similar investment; plus (xvi) any losses from disposed or discontinued operations; plus (xvii) (A) any costs or expenses (including any payroll taxes) incurred by the Borrower or any Subsidiary in such Test Period as a result of, in connection with or pursuant to any management equity plan, profits interest or stock option plan or any other management or employee benefit plan or agreement, any pension plan (including (1) any post-employment benefit scheme to which the relevant pension trustee has agreed, (2) as a result of curtailments or modifications to pension and post-retirement employee benefit plans and (3) without limitation, compensation arrangements with holders of unvested options entered into in connection with a permitted Restricted Payment), any stock subscription, stockholders or partnership agreement, any payments in the nature of compensation or expense reimbursement made to independent board members, any employee benefit trust, any employee benefit scheme or any similar equity plan or agreement (including any deferred compensation arrangement), including any payment made to option holders in connection with, or as a result of, any distribution being made to, or share repurchase from, a shareholder, which payments are being made to compensate option holders as though they were shareholders at the time of, and entitled to share in, such distribution or share repurchase and (B) any costs or expenses incurred in connection with the rollover, acceleration or payout of Equity Interests held by management of the Borrower and/or any Subsidiary); plus (xviii) [reserved]; plus (xix) the cumulative effect of a change in accounting principles; plus (xx) addbacks reflected in any quality of earnings report prepared by a nationally recognized accounting firm and furnished to the Administrative Agent, in connection with an acquisition consummated after the Closing Date; plus (xxi) the amount of “run rate” cost savings, operating expense reductions and other cost synergies that are projected by the Borrower in good faith to result from actions taken, committed to be taken or expected to be taken no later than 18 months after the end of such Test Period (which amounts will be determined by the Borrower in good faith and calculated on a pro forma basis as though such amounts had been realized on the first day of the Test Period for which Consolidated Adjusted EBITDA is being determined), net of the amount of actual benefits realized during such Test Period from such actions; provided that, in the good faith judgment of the Borrower such cost savings are reasonably

16 identifiable, reasonably anticipated to be realized and factually supportable (it being agreed that such determinations need not be made in compliance with Regulation S-X or other applicable securities law); plus (xxii) to the extent not included in Consolidated Net Income for such period, cash actually received (or any netting arrangement resulting in reduced cash expenditures) during such period so long as the non-cash gain relating to the relevant cash receipt or netting arrangement was deducted in the calculation of Consolidated Adjusted EBITDA for any previous period and not added back; plus (xxiii) the amount of fees, expense reimbursements and indemnities paid to directors and/or members of advisory boards; and (b) decreased, without duplication, by the following items of such Person and its Subsidiaries for such Test Period determined on a consolidated basis in accordance with GAAP (solely to the extent increasing Consolidated Net Income): (xxiv) any amount which, in the determination of Consolidated Net Income for such period, has been included for any non-cash income or non-cash gain, all as determined in accordance with GAAP (provided that if any non-cash income or non-cash gain represents an accrual or deferred income in respect of potential cash items in any future period, such Person may determine not to deduct the relevant non-cash gain or income in the then-current period); plus (xxv) the amount of any cash payment made during such period in respect of any non-cash accrual, reserve or other non-cash charge that is accounted for in a prior period and that was added to Consolidated Net Income to determine Consolidated Adjusted EBITDA for such prior period and that does not otherwise reduce Consolidated Net Income for the current period; plus (xxvi) any unusual, extraordinary or non-recurring gains. Notwithstanding the foregoing, the aggregate amount added back pursuant to clauses (a)(vi), (vii) and (xxi) shall not exceed 15% of the Consolidated Adjusted EBITDA for such Test Period (measured after to giving effect to such items). “Consolidated Capital Expenditures” means, for any period, the aggregate amount of all expenditures of the Borrower and its Subsidiaries during such period determined on a consolidated basis that, in accordance with GAAP, are or should be included as additions to property, plant and equipment in the consolidated statement of cash flows of the Borrower. Notwithstanding the foregoing, Consolidated Capital Expenditures shall not include: (a) expenditures made with tenant allowances received by the Borrower or any of its Subsidiaries from landlords in the ordinary course of business and subsequently capitalized; (b) any amounts spent in connection with Investments permitted pursuant to Section 7.02, Permitted Acquisitions and expenditures made in connection with the Transactions; (c) expenditures financed with the proceeds of an issuance of capital stock of the Borrower, or any cash capital contribution to the Borrower;

会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

会社

EX-99.1 3 oscarhealthfourthquarteran.htm EX-99.1 Document

会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初め

会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。

会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体

会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社

会社開示情報をすべてご覧になるには株探プレミアムの登

会社開示情報をすべてご覧になるには株探

会社開示情報をすべてご覧に

会社開示情報をすべてご覧になるには株探プレミアムの

会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要で

会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの

会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミア

会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧に

会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧に

会社開示情報をすべてご覧になるには株探プレミアムの登

会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中

会社開示情報をすべてご覧になるには株探

会社開示情報をすべてご覧に

会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。

会社開示情報をすべてご覧になるには株探プレミアムの登録が必要で

会社開示情報をすべてご覧になるには株探プレミ

会社開示情報をすべてご覧になるには株探

会社開示情報をすべてご覧に

会社開示情報をすべてご覧になるには株探

Investor Contact:

Chris Potochar

VP of Investor Relations

ir@hioscar.com

会社開示情報をすべてご覧になる

Kristen Prestano

VP of Communications

press@hioscar.com

会社開示情報をすべてご覧になるには株探プレミアム

会社開示情報をすべてご覧になるには株探

会社開示情報をすべてご覧に

会社開示情報をすべてご覧になるには株探

会社開示情報をすべてご

会社開示情報

会社開示情報をすべてご覧になるには株探

会社開示情報をすべてご覧に

会社開示情報をすべてご覧になるには株探

会社開示情報をすべてご覧になるには株探プレミアムの登録が

会社開示情報

会社開示情報をすべてご覧になるには株探

会社開示情報をすべてご覧に

会社開示情報をすべてご覧になるには株探

会社開示情報をすべてご覧にな

会社開示情報

会社開示情報をすべてご覧になるには株探

会社開示情報をすべてご覧に

会社開示情報をすべてご覧になるには株探プレミア

会社開示情

会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30

会社開示情報をすべてご覧になるには株探

会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です

会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレ

会社開示情報をすべてご覧になるには株探プ

会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めて

会社開示情報をすべてご覧になるには株探

会社開示情報をすべてご覧に

会社開示情報をすべて

会社開示情報をすべてご覧になるには株探

会社開示情報をすべてご覧に

会社開示情報をすべ

会社開示情報をすべてご覧になるには株探

会社開示情報をすべてご覧に

会社開示情報をすべてご覧になるには株探

会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご

会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施

会社開示情報をすべてご覧になるには株探プレミアムの登録が必要です。初めての方には「30日間の無料体験」実施中！会社開示